首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis
【24h】

Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis

机译:Semaphorin 4D提供了轴突引导过程与肿瘤诱导的血管生成之间的联系

获取原文
获取原文并翻译 | 示例
       

摘要

Tumor progression and metastasis depend on the ability of cancer cells to initiate angiogenesis and ensure delivery of oxygen, nutrients, and growth factors to rapidly dividing transformed cells and provide access to the systemic circulation. In addition to well established growth factors and inflammatory mediators that promote capillary sprouting and endothelial cell growth and migration, an emerging body of evidence supports a previously unrecognized function for axon guidance molecules in regulation of blood vessel development. Here we show that semaphorin 4D (Sema4D) a protein originally shown to regulate axonal growth cone guidance in the developing central nervous system through its receptor, plexin-B1, is highly expressed in cell lines derived from head and neck squamous cell carcinomas (HNSCCs) at both the protein and message level. Immunohistochemical analysis of a large collection of HNSCC specimens revealed high levels of Sema4D in a cell surface pattern in invading islands of transformed epithelial cells, but not in normal and noninvasive dysplastic epithelium. A similar pattern was observed in malignant cells from prostate, colon, breast, and lung cancer tissues. When shed from HNSCC cells, Sema4D stimulates endothelial cell migration, which can be prevented by Sema4D-blocking antibodies and by Sema4D knockdown. Furthermore, knocking down Sema4D by lentiviral expression of Sema4D shRNA reduces dramatically the size and vascularity of HNSCC tumor xenografts. These findings indicate that expression of Sema4D is a frequently used strategy by which a wide variety of carcinomas may promote angiogenesis, and therefore is a possible therapeutic target for the treatment of these malignancies.
机译:肿瘤的进展和转移取决于癌细胞启动血管生成并确保输送氧气,营养物质和生长因子以迅速分裂转化细胞并提供进入全身循环的能力。除了成熟的促进毛细血管萌芽和内皮细胞生长与迁移的生长因子和炎性介质外,越来越多的证据支持轴突引导分子在调节血管发育中的功能,这一点以前未被认识。在这里,我们显示信号蛋白4D(Sema4D)最初显示为通过其受体plexin-B1调节中枢神经系统中轴突生长锥的指导蛋白,在头颈部鳞状细胞癌(HNSCCs)衍生的细胞系中高度表达在蛋白质和信息水平上。大量HNSCC标本的免疫组织化学分析显示,在转化的上皮细胞浸润的岛中,细胞表面模式中的Sema4D含量很高,但正常和非侵入性增生上皮细胞中却没有。在前列腺,结肠,乳腺癌和肺癌组织的恶性细胞中观察到类似的模式。当从HNSCC细胞脱落时,Sema4D刺激内皮细胞迁移,这可以通过Sema4D阻断抗体和Sema4D敲低来阻止。此外,通过慢病毒表达的Sema4D shRNA敲低Sema4D可显着降低HNSCC肿瘤异种移植物的大小和血管。这些发现表明,Sema4D的表达是广泛使用的策略,通过该策略,各种各样的癌均可促进血管生成,因此是治疗这些恶性肿瘤的可能治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号